All Sauce from Weekly Sauce:

Outside advisors for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions. Although most of the Pulmonary-Allergy Drugs Advisory Committee members supported the spray for adults (16:6) and children (17:5), key questions linger about whether more data is needed from its maker,…  read on >  read on >

FRIDAY, May 12, 2023 (American Heart Association News) — With her suitcase in tow, Kathy Wilson-Gold dropped off her 6-year-old twins, Michael and Megan, at school on a sunny Monday in October, then drove to the airport for a business trip to New Jersey. The health care executive and registered dietitian’s first flight from her…  read on >  read on >

Asthma can be a tough disease to control, but to control it you first need to know if you have it. A chronic condition, there are telltale symptoms that crop up when an asthma attack strikes and knowing what those are could help you avoid a life-threatening emergency. According to the most recent data from…  read on >  read on >

(HealthDay News) – Millions of Americans take cholesterol-lowering drugs called statins, but a new study finds Black and Hispanic adults get the drugs less often than white people do. “This adds to the known racial and ethnic disparities already highly prevalent in heart disease,” said lead author Dr. Ambarish Pandey, an assistant professor of internal…  read on >  read on >

(HealthDay News) – If you’re one of the millions of folks with sleep apnea, you may be more likely to develop long COVID, a new study suggests. Adults with obstructive sleep apnea were 75% more likely to experience long COVID symptoms than people without the disorder, which is marked by pauses in breathing during sleep.…  read on >  read on >